NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial

NCT00337181

CompletedN/A

Sponsor: U.S. Army Medical Research and Development Command

Conditions: HIV-1

Countries: Thailand

This protocol will study the clinical course of HIV-infection among volunteers who have received either a placebo injection or the experimental vaccine combination of ALVAC-HIV and AIDSVAX B/E prior to HIV-1 infection in reference to study NCT00223080 RV144. The study will assess whether those who received the experimental vaccine combination have a slower progression of HIV disease compared to those who received the placebo injection.

Eligibility overview

Sex: ALL

Age: 18 Years to 31 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* All individuals who become HIV-infected after receiving experimental vaccine or placebo in the RV144 clinical trial if they received at least one injection.
* The volunteer must give written, informed consent.

Exclusion Criteria:

* Persons who have a medical or psychiatric disorder, that in the judgment of the investigator(s), would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent.
* Persons who become HIV-infected after the completion of the RV144 protocol.

Locations (1)

Chon Buri, Chon Buri Province, Thailand